Proposed Legislation Would Regulate Stem Cell Therapy Clinic Claims


(Olympia, Washington) — If proposed legislation wins approval in Olympia next week – many clinics promoting stem cell therapy will have to make it clear when the treatment they’re selling is not approved by the Food and Drug Administration.

Right now, the only proven stem cell therapies deal with blood regeneration- treatments such as bone marrow transplants, cord blood transplants and similar procedures that have been well documented to regenerate your blood forming abilities.

Stem cell researchers, medical experts and researchers at the FDA warn everything else is experimental.

Under ESHB 2356, the Stem Cell Therapy Bill being considered in Olympia, facilities offering stem cell treatments must notify you about therapies that are not approved by the FDA. They have to put it in writing and get your written consent.

Full Story

By |February 23rd, 2018|Uncategorized|0 Comments

A&M and Celltex partner on stem cell Alzheimer’s research

Source: Houston Chronicle

(Houston, Texas) — Texas A&M University Health Science Center is partnering with the Houston company that ran into trouble with federal regulators a year after facilitating the 2011 stem cell treatment of Gov. Rick Perry’s ailing back.

Celltex Therapeutics Corp. and A&M’s Institute for Regenerative Medicine Tuesday announced an intellectual property licensing deal involving research on a potential stem cell therapy for Alzheimer’s disease. A&M researchers say the therapy shows promise where drugs typically fail.

“In mice to whom we did terrible things to damage brain function, this therapy restored memory,” said Dr. Darwin Prockop, director of the A&M Institute for Regenerative Medicine and the leader of the laboratory team working on the project. “Through this deal, we hope to start bringing it to human patients within three years.”

Celltex will pay Texas A&M $2.4 million to acquire the technology and ultimately bring it to market.

Full Story

By |February 7th, 2018|Uncategorized|0 Comments

First Cow Embryonic Stem Cells Derived

Source: Science Magazine

(East Lansing, Mich.) — After decades of effort, scientists have finally managed to derive embryonic stem (ES) cells from cows and keep them in their primitive state in a dish. Access to these versatile cells, which can become all kinds of tissues, from skin to muscle to bone, could make it easier to tweak and preserve useful genetic traits of beef and dairy breeds. That in turn could lead to animals that produce more milk or more tender meat, face fewer complications in giving birth, or have greater resistance to diseases. The discovery might also open up new ways to study the cow’s basic development and to model human diseases.

“I thought I would never see this happen in my lifetime,” says Jose Cibelli, a developmental biologist at Michigan State University in East Lansing, who was part of a team that attempted to harvest bovine ES cells in the late 1990s. In those efforts and many others since, stem cells from cow embryos would develop into other cell types when grown in a lab dish, meaning that they would quickly lose their “stemmy-ness,” or pluripotency.

Researchers turned their eyes to cattle soon after the mouse gave up its ES cells in 1981, allowing researchers to study early embryonic development and test the effects of genetic defects. But other species have been more difficult. It would take researchers until 1998 to find the right broth of nutrients to culture human ES cells.

Full Story

By |February 6th, 2018|Uncategorized|0 Comments